Search company, investor...


Founded Year



Unattributed - XXXI | Alive

Total Raised


Last Raised

$160K | 1 yr ago



About HealthTronics

HealthTronics provides integrated urological and interventional radiology products and services, as well as physician partnership opportunities. The company brings its technology and support systems to health care providers across the United States.

Headquarters Location

9825 Spectrum Drive Bldg. 3

Austin, Texas, 78717,

United States


Missing: HealthTronics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: HealthTronics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing HealthTronics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

HealthTronics is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,721 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

HealthTronics Patents

HealthTronics has filed 3 patents.

patents chart

Application Date

Grant Date


Related Topics




Fuel cells, Hydrogen technologies, Neurophysiology, Electrophysiology, Electrochemistry


Application Date


Grant Date



Related Topics

Fuel cells, Hydrogen technologies, Neurophysiology, Electrophysiology, Electrochemistry



Latest HealthTronics News

Global Tumor Ablation Market Research 2022 to 2028: Featuring BTG, BVM Medical, Erbe Elektromedizin, Healthtronics and Hologic Among Others -

Feb 2, 2023

Stryker Furthermore, various advantages offered by tumor ablation techniques such as speedy recovery, reduced complication, and shorter hospitals stay, the technique is gaining traction in coming years. Tumor ablation refers to a minimally invasive (MI) technique used for the treatment of tumors of the kidney, liver, and lungs. It is conducted through microwave ablation, radiofrequency ablation, cryoablation, and others. Moreover, the rising number of brain tumors, and government initiatives to create awareness related to various cancers, boost the market growth. Brain tumors comprise a wide range of central nervous system tumors that ranges from non-malignant tumors to most complex cancers such as glioblastoma and diffuse intrinsic pontine glioma. According to the National Brain Tumor Society, an estimated 700,000 people in the US are living with a primary brain tumor, and nearly 90,000 more is diagnosed in 2022. Moreover, the average survival rate for all malignant brain tumor patients is only 36%, and it is one of the major causes of death in children and young adults aged 19 and younger. The global tumor ablation market is segmented on the basis on technology, application, and end user. Based on technology, the market is sub-segmented into radio frequency ablation, microwave ablation, cryoablation, and percutaneous ethanol ablation. Based on application, the market is bifurcated into liver cancer, lung cancer, breast cancer, prostate cancer, and others. Based on end user, the market is sub-divided into hospitals, surgical clinics, and research institutions. Based on technology, the microwave ablation segment is holding a major share from its inception. Microwave ablation systems are gaining popularity over conventional surgeries to treat or destroy cancerous cells, and this procedure offers many advantages over conventional and other techniques, which increases the demand for microwave ablation in coming years. Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The European region is anticipated to grow at the fastest rate; presence of immense healthcare institutions, and the availability of advanced and innovative technological medical tools and devices for the tumor treatment, enhances the growth of the global tumor ablation market in the region. Moreover, the insurance coverage and benefits given by key insurance companies such as, Axa, Allianz SE, and Zurich Insurance Group, to people for treating major diseases which include tumor and diabetes, results in boosting the market growth. The major companies serving the global tumor ablation market are Boston Scientific Corp., BTG plc, BVM Medical Ltd., Erbe Elektromedizin GmbH, Healthtronics, Inc., Hologic Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2022, Engenious and Precision Microwave have developed a new system for minimally invasive thermal ablation treatment for cancers, a novel treatment tool with the ability to reduce the risk of tumors. Thermal ablation is a type of procedure that uses heat, cold, microwave, and electrical currents to vaporize cancer cells and tumors. The Report Covers This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the global tumor ablation market. Insights about market determinants that are stimulating the global tumor ablation market. Detailed and extensive market segments with the regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. Key Topics Covered:

HealthTronics Frequently Asked Questions (FAQ)

  • When was HealthTronics founded?

    HealthTronics was founded in 1989.

  • Where is HealthTronics's headquarters?

    HealthTronics's headquarters is located at 9825 Spectrum Drive, Austin.

  • What is HealthTronics's latest funding round?

    HealthTronics's latest funding round is Unattributed - XXXI.

  • How much did HealthTronics raise?

    HealthTronics raised a total of $2.18M.

  • Who are the investors of HealthTronics?

    Investors of HealthTronics include Altaris Capital Partners and Endo International.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.